ALTERITY THERAPEUTICS LTD

Alterity Therapeutics spikes despite weak fundamentals, a speculative rally in a low‑liquidity biotech sector that may signal a fleeting price flare.

Alterity Therapeutics (ATH.AX) falls 5.56% on 23 Oct 2026, trading at AUD 0.26. With a market cap of AUD 55.7 m and 12‑month range AUD 0.78 to 0.24, the biotech focuses on Alzheimer’s therapies. Click to learn more.

Alterity Therapeutics’ steep 15.6% fall shows how CEO pay changes amid a price collapse can erode trust and expose shaky pipeline prospects.